MELISSA TURNER: Open Payments
NPI 1396996039 · EVERETT, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$603 in 10 payments from 4 companies in 2025. Trend: 2023 $517 · 2024 $116 · 2025 $603
Food & beverage: $591Education: $12
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 6 | $320 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $142 |
| Vanda Pharmaceuticals Inc. | 1 | $124 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
Products named: Auvelity, CAPLYTA, FANAPT, Qelbree.
Industry payments across WA — which companies pay providers there.
